Ultima Genomics and NVIDIA Collaborate on Pangenome Sequencing Analysis
Ultima Genomics announced in a press release a collaboration with NVIDIA on pangenome aware analysis for whole genome sequencing. The work combines Ultima's sequencing platform, NVIDIA accelerated computing and Google's open source DeepVariant software.
The companies are benchmarking workflows that use pangenome graph alignment against conventional linear reference pipelines. Testing uses genetically diverse human genomes, high confidence reference data and resources from the Human Pangenome Reference Consortium.
The project also covers infrastructure for processing large sequencing datasets. NVIDIA Parabricks provides versions of Giraffe and DeepVariant that use graphics processors for alignment and variant calling.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly, Enterprise AI Brief or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 27 Anthropic Reports Early Claude Results in Drug Development Oct 27 Insilico Reports Early ISM6331 Responses in Mesothelioma Oct 27 UnitedHealthcare Expands Avery AI Assistant to 21 Million Members Oct 27 Atlas Bio raises $12.5 million for virtual drug trials Oct 27 Adsilico Raises £10 Million for Virtual Medical Device TestingMore from Enterprise
Oct 27 Amazon Warns Engineers Against Tokenmaxxing Oct 27 Harmonic Expands Aristotle Into Software and Chip Verification Oct 27 Cisco Introduces Model Foundry for Specialized AI Models Oct 27 Noyb Files Five European Privacy Complaints Against Scale AI Oct 27 Cognition Expands London Presence After UK Team Grows More Than 200%Enterprise AI Brief
Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Genedata Adds NVIDIA RFD4-Proteina to Biologics Discovery Workflows
Illumina Adds Three Research Tools to BioInsight Platform
Illumina Launches BioInsight Platform for Genomic Research
NVIDIA Debuts RFD4-Proteina and Expands Radiotherapy Work
INmune Bio and QCi Apply Quantum Computing to XPro Research
Daily AI Brief: the AI news that matters, in your inbox.